Ethics Committee Reviews of Applications for Research Studies at 1 Hospital in China During the 2019 Novel Coronavirus Epidemic

JAMA. 2020 May 12;323(18):1844-1846. doi: 10.1001/jama.2020.4362.

Abstract

This study reviews research ethics committee applications for COVID-19–related research at a Chinese hospital in February 2020 to characterize study type, approval rate and review time, reason for revision or denial, and issues with informed consent.

MeSH terms

  • Antiviral Agents / therapeutic use
  • Betacoronavirus*
  • Biomedical Research / standards*
  • Biomedical Research / statistics & numerical data
  • COVID-19
  • China / epidemiology
  • Consent Forms / standards
  • Consent Forms / statistics & numerical data
  • Containment of Biohazards / standards
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / therapy
  • Ethics Committees, Research / standards*
  • Humans
  • Interferon-alpha / therapeutic use
  • Medicine, Chinese Traditional / adverse effects
  • Observational Studies as Topic / statistics & numerical data
  • Pandemics
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / therapy
  • Practice Guidelines as Topic / standards*
  • Research Design / standards*
  • Research Design / statistics & numerical data
  • SARS-CoV-2
  • Sample Size
  • Time Factors
  • World Health Organization

Substances

  • Antiviral Agents
  • Interferon-alpha